[CBAY] YoY Quarter Result on 31-Mar-2019 [#Q1]

Stock
[CBAY] CymaBay Therapeutics, Inc.
Announcement Date
08-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- -18.64%
YoY- -35.70%
Quarter Report
CBAY's Result
CBAY's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Revenue 0 0 0 0 0 4,793 0 -
PBT -27,769 -17,551 -13,088 -23,075 -17,005 -5,351 -6,848 26.26%
Tax 3,267 0 -768 1,176 -4,447 -1,829 652 30.79%
NP -31,036 -17,551 -13,088 -23,075 -17,005 -5,351 -6,848 28.62%
Tax Rate - - - - - - - -
Total Cost 31,036 17,551 13,088 23,075 17,005 10,144 6,848 28.62%
Ratio Analysis
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 -111.64 0.00 -
Per Share
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
EPS -0.36 -0.25 -0.19 -0.37 -0.32 -0.20 -0.29 3.66%
EPS Diluted -0.35 -0.25 -0.19 -0.37 -0.32 -0.20 -0.29 3.18%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.